Abstract
The article is of an overview nature. It provides various classifications of pyoderma and infections of the skin and soft tissues, epidemiological data on pyoderma in our country and abroad, discusses in detail local and systemic risk factors for the development of the disease, environmental risk factors. Much attention is paid to comparative studies on the efficacy and safety of mupirocin (Supirocin) in comparison with systemic antibiotics and topical antibacterial agents, indicating the benefits of mupirocin.
Publisher
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov